Authors
Wood is a urologic oncology fellow at Glickman Urological & Kidney Institute at the Cleveland Clinic in Ohio.
Rachelle Manookian, MS, LCGC, is a board-certified genetic counselor specializing in cancer genetics. She has an MS in genetic counseling from the Icahn School of Medicine at Mount Sinai, and a BS in biological sciences with a focus in neurobiology from University of California Irvine, as well as minors in Spanish literature and cognitive psychology.
Chung is a resident at NewYork-Presbyterian/Columbia University Irving Medical Center, New York, New York.
Benidir is a urologic oncology fellow at Cleveland Clinic Glickman Urological and Kidney Institute in Ohio.
Advertisement
Advertisement
Trending on Urology Times
1
How PSMA-PET shapes staging and recurrence workup in prostate cancer
2
European Commission approves perioperative pembrolizumab plus enfortumab vedotin for MIBC
3
Engy Habashy, MD, on the role of androgens in GSM management
4
FDA accepts new drug application for UGN-103 in recurrent LG-IR-NMIBC
5
